Skip to main content

Table 2 Distribution of genotype and allele frequencies of the  hOGG1  Ser326Cys polymorphism

From: An association between hOGG1Ser326Cys polymorphism and the risk of bladder cancer in non-smokers: a meta-analysis

First author [reference]

Genotype

Allele

HWE( p )

Cases n (%)

Controls n (%)

Cases n (%)

Controls n (%)

Ser/Ser

Ser/Cys

Cys/Cys

Ser/Ser

Ser/Cys

Cys/Cys

Ser

Cys

Ser

Cys

Kim (2005) [19]

37 (24.2%)

90 (58.8%)

26 (17.0%)

38 (24.8%)

70 (45.6%)

45 (29.4%)

164 (53.6%)

142 (46.4%)

146 (47.7%)

160 (52.3%)

0.30

Karahalil (2006) [23]

40 (40.4%)

47 (47.5%)

12 (12.1%)

62 (62.0%)

20 (20.0%)

18 (18.0%)

127 (64.1%)

71 (35.9%)

144 (72.0%)

56 (28.0%)

<0.001

Huang (2007) [21]

375 (61.2%)

209 (34.1%)

29 (4.73%)

348 (58.0%)

216 (36.0%)

36 (6%)

959 (78.2%)

267 (21.8%)

912 (76.0%)

288 (24.0%)

0.75

Figueroa (2007) [20]

649 (59.7%)

383 (35.2%)

56 (5.15%)

596 (58.5%)

361 (35.5%)

61 (5.99%)

1681 (77.3%)

495 (22.7%)

1553 (76.3%)

483 (23.7%)

0.52

Arizono (2008) [17]

61 (24.3%)

107 (42.6%)

83 (33.1%)

67 (26.7%)

135 (53.8%)

49 (19.5%)

229 (45.6%)

273 (54.4%)

269 (53.6%)

233 (46.4%)

0.20

Narter (2009)[22]

37 (63.8%)

13 (22.4%)

8 (13.8%)

18 (50.0%)

18 (50.0%)

0 (0%)

87 (75.0%)

29 (25.0%)

54 (75.0%)

18 (25.0%)

0.08

Mittal (2011) [31]

92 (43.4%)

93 (43.9%)

27 (12.7%)

122 (48.8%)

111 (44.4%)

17 (6.8%)

277 (65.3%)

147 (34.7%)

355 (71.0%)

145 (29.0%)

0.21

Total

1291 (52.2%)

942 (38.1%)

241 (9.74%)

1251 (52.0%)

931 (38.7%)

226 (9.39%)

3524 (71.2%)

1424 (28.8%)

3433 (71.3%)

1383 (28.7%)

0.006